Literature DB >> 9178905

Basic fibroblast growth factor transcriptional autoregulation requires EGR-1.

D Wang1, M W Mayo, A S Baldwin.   

Abstract

Basic fibroblast growth factor (bFGF) is an important growth factor for neuroectoderm- and mesoderm-derived cells. In addition bFGF is an important angiogenic factor and appears to contribute to tumorigenesis. This is exemplified by the fact that bFGF is expressed in a large majority of human gliomas and that bFGF expression is critical for the growth and tumorigenesis of these cells. It has been shown previously that bFGF can induce its own expression through an increase in bFGF mRNA. In this report, we show that bFGF leads to its own synthesis through an autoregulated transcriptional response that requires the transcription factor Egr-1 (also known as Krox24, Zif268 and NGFI-A). Egr-1 binds to two DNA elements in the bFGF promoter and positively regulates transcription. Mutation of these sites blocks the ability of bFGF to transcriptionally regulate the bFGF promoter. These data indicate a mechanism to explain how bFGF functions to autoregulate its expression and demonstrate that Egr-1 is as an essential transcription factor in this process.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9178905     DOI: 10.1038/sj.onc.1201069

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

Review 1.  Pathways of Egr-1-mediated gene transcription in vascular biology.

Authors:  E S Silverman; T Collins
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

2.  Suppression of transcription factor early growth response 1 reduces herpes simplex virus 1-induced corneal disease in mice.

Authors:  Hui-Wen Yao; Shih-Heng Chen; Ching Li; Yuk-Ying Tung; Shun-Hua Chen
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

3.  A dyad symmetry element in the fibroblast growth factor-2 gene promoter with different levels of activity in astrocytoma and hepatocelluar carcinoma cell lines.

Authors:  Tetsuya Ueba; Hisae Mori; Jun A Takahashi; Kazuhiko Nozaki; Nobuo Hashimoto
Journal:  J Neurooncol       Date:  2006-05-13       Impact factor: 4.130

4.  Gekko-sulfated glycopeptide inhibits tumor angiogenesis by targeting basic fibroblast growth factor.

Authors:  Shuang-Xia Zhang; Cong Zhu; Yi Ba; Dan Chen; Xing-Long Zhou; Rui Cao; Li-Ping Wang; Yuan Ren; Xiong-Zhi Wu
Journal:  J Biol Chem       Date:  2012-02-25       Impact factor: 5.157

5.  Sequential cytokine therapy for pressure ulcers: clinical and mechanistic response.

Authors:  M C Robson; D P Hill; P D Smith; X Wang; K Meyer-Siegler; F Ko; J S VandeBerg; W G Payne; D Ochs; L E Robson
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

6.  15(S)-hydroxyeicosatetraenoic acid-induced angiogenesis requires Src-mediated Egr-1-dependent rapid induction of FGF-2 expression.

Authors:  Venkatesh Kundumani-Sridharan; Jixiao Niu; Dong Wang; Dong Van Quyen; Qiuhua Zhang; Nikhlesh K Singh; Jaganathan Subramani; Saradasri Karri; Gadiparthi N Rao
Journal:  Blood       Date:  2010-01-06       Impact factor: 22.113

7.  Marine algal carotenoids inhibit angiogenesis by down-regulating FGF-2-mediated intracellular signals in vascular endothelial cells.

Authors:  Ponesakki Ganesan; Kiminori Matsubara; Tatsuya Sugawara; Takashi Hirata
Journal:  Mol Cell Biochem       Date:  2013-04-24       Impact factor: 3.396

8.  Novel mutants of NAB corepressors enhance activation by Egr transactivators.

Authors:  J Svaren; B R Sevetson; T Golda; J J Stanton; A H Swirnoff; J Milbrandt
Journal:  EMBO J       Date:  1998-10-15       Impact factor: 11.598

9.  Early growth response gene mediates in VEGF and FGF signaling as dissected by CRISPR in corpus luteum of water buffalo.

Authors:  Meeti Punetha; Vikrant S Chouhan; Arvind Sonwane; Gyanendra Singh; Sadhan Bag; Jonathan A Green; Kristin Whitworth; Mihir Sarkar
Journal:  Sci Rep       Date:  2020-04-22       Impact factor: 4.379

Review 10.  Fucoxanthin and Its Metabolite Fucoxanthinol in Cancer Prevention and Treatment.

Authors:  Luc J Martin
Journal:  Mar Drugs       Date:  2015-07-31       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.